• INTISAR SALIM PITY Prof, Pathology Dep., College of Medicine, University of Duhok, Duhok, Kurdistan Region of Iraq.
  • SUAD TAHER YASEN Lecturer, Obstetrics & Gynecology Dep., College of Medicine, University of Duhok, Kurdistan Region of Iraq.
  • BANAV NAJEEB MUHAMMED Lecturer, Obstetrics & Gynecology Dep., College of Medicine, University of Duhok, Kurdistan Region of Iraq.
  • OMAR SALIM MUHI Director of Health Duhok, Duhok, Kurdistan region of Iraq.
  • AZAD MUSTAFA AHMAD Lecturer, Basic Sciences Dep, College of Dentistry, University of Duhok, Duhok, Kurdistan Region of Ira
  • FADI BADAL HAYDER Director of Health Duhok, Duhok, Kurdistan region of Iraq.
Keywords: Diagnosis, Immunohistochemistry, Mesenchymal tumors, Uterus



Background: Although malignant uterine mesenchymal tumors are relatively uncommon, their definite diagnosis is crucial for therapeutic as well as prognostic purposes.

Objectives: To study the frequency of uterine mesenchymal tumors in Duhok-Iraq and to highlight the impact of immunohistochemically on warning cases.

Materials and Methods: In this cross-sectional study, 3931 uterine mesenchymal tumors were received in the Departments of Histopathology in Vin Private Laboratories and Central General Laboratories in Duhok-Iraq, over a consecutive period of 13 years (January 2009 to December 2021). Cases were examined morphologically. Equivocal cases were subjected to immunohistochemical workup via UltraVision LP Large Volume Detection System & HRP Polymer (Ready-To-Use) from Thermo Fisher Scientific and using the automated immunostaining technique.

Results: Benign tumors (97.4%) overwhelmed the malignant cases (1%). The remaining 1.6% comprised the smooth muscle tumors of undetermined malignant potential (SUMPT).

Conclusions: Diagnosis and categorization of most benign and malignant uterine mesenchymal tumors is an acumen nuclear histology. However, in unequivocal cases, high-grade cancers and mixed neoplasms, immunohistochemistry is needful and applicable due to its easy methodology. Yet some cases remain doubtful and require advanced techniques for definite diagnosis.  


Download data is not yet available.


1. Toledo G, Oliva E. Smooth Muscle Tumors of the Uterus. A Practical Approach. Arch Pathol Lab Med. 2008;132:595–605
2. Parra-Herran C, Howitt BE. Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features. Surgical Pathology Clinics; 2019;12(2):363-96.
3. Oliva E. Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia. Modern Pathology. 2016;29:S104-S120.
4. Carvalho FM, Carvalho JP, Alves Pereira RM, Junior BPVC, Lacordia R, BaracatEC. LeiomyomatosisPeritonealisDisseminata Associated with Endometriosis and Multiple Uterus-Like Mass: Report of Two Cases. Clin Med Insights Case Rep. 2012; 5: 63–8.
5. Philip P C Ip , Ka YT, Kar FT. Uterine Smooth Muscle Tumors Other Than the Ordinary Leiomyomas and Leiomyosarcomas: A Review of Selected Variants with Emphasis on Recent Advances and Unusual Morphology That May Cause Concern for Malignancy. Advances in Anatomic Pathology: 2010; 17(2):91-112.
6. Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J GynecolPathol. 2008;27(3):326-32.
7. Hornick JL. Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors. Modern Pathology. 2014;27:S47–S63.
8. Rubisz P, Ciebiera M, Hirnle L, Zgliczynska M, Tonizinki T, Dziegiel P, et al. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium. Int J Mol Sci. 2019;6:20(5):1136.
9. Pity IS, Muhi OS. Prevalence of Soft Tissue Tumours in Duhok-IraqA Practical Immunohistochemical Approach. JCDR. 2020;14(10): 21-26.
10. Ishidera Y, Yoshida H, Oi Y, Katyama K, Miyagi E, Hayashi H, et al. Analysis of uterine corporeal mesenchymal tumors occurring after menopause. BMC Women's Health. 2019; 19(13):doi: 10.1186/s12905-019-0714-5.4.
11. Chen X, Arend R, Hamele-Bena D, Tergas AI, Hawver M, Tong G-X, et al. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics. Int J GynecolPathol. 2017;36(5):412-419.
12. Pity IS, Younus SA. Paediatric Malignant Blue Cell Tumours- A Practical Pathological and Immunohistochemical Study in Duhok, Iraq. JCDR. 2020;14(9):10-15.)
13. Bayder DF, Armutlu A, Aydin O, Daqdemir A, Yakuploglu YK. Desmoplastic small round cell tumor of the kidney: a case report. Diagnostic Pathology. 2020;15(95):1-9.
14. Pity IS, Jalal AJ, Hassawi BA. Hysterectomy. A Clinicopathologic Study. Tikrit Medical Journal. 2011;17(2):7-16.
15. Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence symptoms and management of uterine fibroids: an international internet-based survey of 21, 746 women. BMC Women Health. 2012;12(6):1-7.
16. Busca A, Parra-Herran C. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis. Adv AnatPathol. 2017;24(6):354-61.
17. Kita A, Maeda T, Kitajima K, Murakoshi H, Watanabe T, Inagaki M, Yoshida S. Epithelioid leiomyoma of the uterus: A case report with magnetic resonance. Women’s health. 2022;34:00386.
18. Sikora-Szczęśniak DL. Uterine angioleiomyoma - a rare variant of uterine leiomyoma: review of literature and case reports. PrzMenopauzalny. 2016;15(3):165-9.
19. Meena LN, Aggarwal A, Jain S. Cotyledonoid Leiomyoma of Uterus.J ObstetGynaecol India. 2014; 64(2): 146–7.
20. Morales MM, Anacleto A, Leal CL, Caryalho S, Del’Arco J. Intravascular leiomyoma with heart extension. Clinics (Sao Paulo). 2012;67(1): 83–7.
21. Wasyluk T, Obrzut B, Gałązka K, Żmuda M, Obrzut M, Darmochwał-Kolarz D. Uterine myoma with massive lymphocytic infiltration – case report. PrzMenopauzalny. 2019;18(2):123–5.
22. . Zheng Y-Y, Liu X-B, Lin M-H. Smooth muscle tumor of uncertain malignant potential (STUMP): a clinicopathologic analysis of 26 cases. Int J Clin Exp Pathol. 2020;13(4):818-26.
23. El Agwany AS, Meleis M. Cervical angiomyxoma: a rare benign and recurrent cervical mass simulating common pathologies. Indian Journal of Gynecologic Oncology volume 2018; 16(34).
How to Cite
SALIM PITY, I., TAHER YASEN, S., NAJEEB MUHAMMED, B., SALIM MUHI, O., MUSTAFA AHMAD, A., & BADAL HAYDER, F. (2023). UTERINE MESENCHYMAL TUMORS IN DUHOK-IRAQ. A PRACTICAL PATHOLOGICAL STUDY. Duhok Medical Journal, 17(2), 71-85. Retrieved from https://dmj.uod.ac/index.php/dmj/article/view/262